Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:55 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Comparison of Oxytocin Receptor Immunoreactivity in Placentas Obtained From Women Having Cesarean and Natural Birth

ClinicalTrials.gov · NCT06275438 · Registry updated: 2024-02-23

Condition / research focus: Healthy Mothers Who Have Had Both Vaginal and Cesarean Deliveries
Sponsor: Kafkas University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2018-08-25. Completion: 2019-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

The delivery being performed via cesarean section surgery rather than natural childbirth (other)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Kafkas Universty
Kars, Merkez, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin for Oxidative Stress and Inflammation

ClinicalTrials.gov · NCT04732247 · Registry updated: 2024-02-22

Condition / research focus: Oxidative Stress; Inflammation
Sponsor: Florida Institute for Human and Machine Cognition
Countries with listed sites: United States
Registry dates and results: Start: 2022-02-01. Completion: 2023-09-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Oxytocin
Placebo nasal spray (drug) — also listed as: Placebo

Where the study takes place — 3 listed sites

Translational Genomics Research Institute
Phoenix, Arizona, United States
Site recruitment: Not reported
University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported
Florida Institute for Human and Machine Cognition
Pensacola, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants

ClinicalTrials.gov · NCT02205034 · Registry updated: 2024-02-21

Condition / research focus: Prader Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2013-05. Completion: 2014-07 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: Oxytocin (Syntocinon)

Where the study takes place — 1 listed sites

Centre de réfrence Prader-Willi, Hospital of infants
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH

ClinicalTrials.gov · NCT02775773 · Registry updated: 2024-02-08

Condition / research focus: Post Partum Haemorrhage
Sponsor: Azienda U.S.L. 1 di Massa e Carrara
Countries with listed sites: Italy
Registry dates and results: Start: 2018-01-30. Completion: 2018-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid (drug) — also listed as: TXA
Oxytocin (drug) — also listed as: OXY

Where the study takes place — 1 listed sites

Department of Ostetricia e Ginecologia-Ospedale delle Apuane
Massa, MS, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3WithdrawnINTERVENTIONAL

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015)

ClinicalTrials.gov · NCT02503319 · Registry updated: 2024-02-08

Condition / research focus: Postpartum Hemorrhage
Sponsor: Azienda U.S.L. 1 di Massa e Carrara
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-01. Completion: 2016-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid (drug) — also listed as: TXA
Tranexamic Acid (drug) — also listed as: TXA
Oxytocin (drug) — also listed as: OXY

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

ClinicalTrials.gov · NCT02545127 · Registry updated: 2024-02-07

Condition / research focus: Preterm Delivery; Inadequate Milk Production
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2021-05-28. Completion: 2022-11-11 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merotocin (drug) — also listed as: FE 202767
Placebo (drug)

Where the study takes place — 10 listed sites

Ferring Investigational Site
New Haven, Connecticut, United States
Site recruitment: Not reported
Ferring Investigational Site
South Bend, Indiana, United States
Site recruitment: Not reported
Ferring Investigational Site
Baltimore, Maryland, United States
Site recruitment: Not reported
Ferring Investigational Site
Boston, Massachusetts, United States
Site recruitment: Not reported
Ferring Investigational Site
Valhalla, New York, United States
Site recruitment: Not reported
Ferring Investigational Site
Raleigh, North Carolina, United States
Site recruitment: Not reported
Ferring Investigational Site
Cincinnati, Ohio, United States
Site recruitment: Not reported
Ferring Investigational Site
Charleston, South Carolina, United States
Site recruitment: Not reported
Ferring Investigational Site
Houston, Texas, United States
Site recruitment: Not reported
Ferring Investigational Site
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

The Effects of Oxytocin in Obese Adults

ClinicalTrials.gov · NCT03043053 · Registry updated: 2024-02-07

Condition / research focus: Obesity
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2017-07-01. Completion: 2022-07-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin nasal spray (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

After Caesarean Section Oxitocin Breast Massage Anthropometric Characteristics of the Newborn

ClinicalTrials.gov · NCT06242886 · Registry updated: 2024-02-05

Condition / research focus: Breastfeeding, Exclusive; Breastfeeding
Sponsor: Halic University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2023-02-20. Completion: 2023-09-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin massage (behavioral)
and Breast massage (behavioral)

Where the study takes place — 1 listed sites

Fatma Şule Bilgiç
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Oxytocin Nasal Inhalation on Empathy Analgesia

ClinicalTrials.gov · NCT05823441 · Registry updated: 2024-02-01

Condition / research focus: Oxytocin; Pain; Empathy; Social Familiarity; Analgesia
Sponsor: Peking University People's Hospital
Countries with listed sites: China
Registry dates and results: Start: 2023-06-03. Completion: 2024-01-21 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Placebo (drug)
Stranger (behavioral)
Acquaintance (behavioral)

Where the study takes place — 1 listed sites

Peking University People's Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Treating Stress and Anxiety in Individuals With Alcohol Use Disorder (AUD)

ClinicalTrials.gov · NCT06224127 · Registry updated: 2024-01-25

Condition / research focus: Anxiety Disorders; Alcohol Use Disorder; Stress, Psychological
Sponsor: Soovu Labs Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2024-07-15. Completion: 2025-03-30 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

active heat (device)
Active c tactile fiber stimulation (drug)
sham heat (device)
Sham c tactile fiber stimulation (device)

Where the study takes place — 1 listed sites

Soovu Labs Inbc.
Seattle, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of Oxytocin on Reinforcement Learning and Interoception

ClinicalTrials.gov · NCT05245708 · Registry updated: 2024-01-19

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2021-04-15. Completion: 2021-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug)
intranasal placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China (UESTC)
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Cerebral Synchronization Between Mothers and Their Newborns During Breastfeeding

ClinicalTrials.gov · NCT05821569 · Registry updated: 2024-01-18

Condition / research focus: Depression, Postpartum
Sponsor: IRCCS Burlo Garofolo
Countries with listed sites: Italy
Registry dates and results: Start: 2024-01-09. Completion: 2024-09-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Standard approach (other)
Biological nurturing (other)

Where the study takes place — 1 listed sites

IRCCS Burlo Garofolo
Trieste, Italy
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Association Between Labor Induction and Birth Weight in Cases of Fetal Macrosomia: The MACROMODA Cohort Study

ClinicalTrials.gov · NCT06198881 · Registry updated: 2024-01-10

Condition / research focus: Birth Weight; Macrosomia, Fetal
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2023-10-01. Completion: 2024-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 3 listed sites

Hôpital Femme-Mère-Enfant
Bron, France
Site recruitment: Not reported
Croix Rousse Hospital
Lyon, France
Site recruitment: Not reported
Hôpital Lyon Sud
Pierre-Bénite, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Uterine Massage After Vaginal Delivery

ClinicalTrials.gov · NCT03858569 · Registry updated: 2024-01-09

Condition / research focus: Postpartum Hemorrhage
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2019-01-15. Completion: 2019-09-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

active management of third stage of labor (procedure)

Where the study takes place — 1 listed sites

Kanuni SSTRH
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes

ClinicalTrials.gov · NCT06181396 · Registry updated: 2023-12-26

Condition / research focus: Delivery Complication; Cesarean Delivery Affecting Fetus
Sponsor: Rambam Health Care Campus
Countries with listed sites: Israel
Registry dates and results: Start: 2023-10-01. Completion: 2026-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Rambam medical health campus
Haifa, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Cervical Traction and Postpartum Hemorrhage

ClinicalTrials.gov · NCT06179147 · Registry updated: 2023-12-21

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ege University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2022-11-01. Completion: 2023-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cervical traction (other)

Where the study takes place — 1 listed sites

Ege University Faculty of Health Sciences
Karşiyaka, İ̇zmi̇r, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Reactivity of Patients With Borderline Personality Disorder to an Ecological Interpersonal Stress

ClinicalTrials.gov · NCT03602521 · Registry updated: 2023-12-20

Condition / research focus: Female; Borderline Personality Disorder
Sponsor: University Hospital, Montpellier
Countries with listed sites: France
Registry dates and results: Start: 2019-02-27. Completion: 2023-08-18 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Interpersonal stress (other)

Where the study takes place — 1 listed sites

Hospital Lapeyronie
Montpellier, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Intranasal Oxytocin for Frontotemporal Dementia

ClinicalTrials.gov · NCT03260920 · Registry updated: 2023-12-15

Condition / research focus: Frontotemporal Dementia
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Countries with listed sites: Canada · United States
Registry dates and results: Start: 2018-01-31. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug) — also listed as: Intranasal Oxytocin

Where the study takes place — 11 listed sites

UCLA
Los Angeles, California, United States
Site recruitment: Not reported
University of California, San Francisco
San Francisco, California, United States
Site recruitment: Not reported
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States
Site recruitment: Not reported
Columbia University Medical Center
New York, New York, United States
Site recruitment: Not reported
University of Washington
Seattle, Washington, United States
Site recruitment: Not reported
University of British Columbia
Vancouver, British Columbia, Canada
Site recruitment: Not reported
Parkwood Institute
London, Ontario, Canada
Site recruitment: Not reported
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Site recruitment: Not reported
University Health Network
Toronto, Ontario, Canada
Site recruitment: Not reported
Montreal Neurological Institute and Hospital
Montreal, Quebec, Canada
Site recruitment: Not reported
Laval University
Québec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Carbetocin in the Prevention of Primary Postpartum Haemorrhage

ClinicalTrials.gov · NCT06159959 · Registry updated: 2023-12-07

Condition / research focus: Post Partum Hemorrhage
Sponsor: Ministry of Health and Population, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2023-01-01. Completion: 2023-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Oxytocin

Where the study takes place — 1 listed sites

Kasr- Alainy Hospitals
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity

ClinicalTrials.gov · NCT05289869 · Registry updated: 2023-11-29

Condition / research focus: Pregnant Patients With Obesity
Sponsor: Ohio State University
Countries with listed sites: United States
Registry dates and results: Start: 2022-04-06. Completion: 2022-10-28 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

High-dose oxytocin (drug)
Low-dose oxytocin (drug)

Where the study takes place — 1 listed sites

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:55 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Comparison of Oxytocin Receptor Immunoreactivity in Placentas Obtained From Women Having Cesarean and Natural Birth

ClinicalTrials.gov · NCT06275438 · Registry updated: 2024-02-23

Condition / research focus: Healthy Mothers Who Have Had Both Vaginal and Cesarean Deliveries
Sponsor: Kafkas University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2018-08-25. Completion: 2019-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

The delivery being performed via cesarean section surgery rather than natural childbirth (other)

Where the study takes place — 1 listed sites

Kafkas Universty
Kars, Merkez, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin for Oxidative Stress and Inflammation

ClinicalTrials.gov · NCT04732247 · Registry updated: 2024-02-22

Condition / research focus: Oxidative Stress; Inflammation
Sponsor: Florida Institute for Human and Machine Cognition
Countries with listed sites: United States
Registry dates and results: Start: 2022-02-01. Completion: 2023-09-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Oxytocin
Placebo nasal spray (drug) — also listed as: Placebo

Where the study takes place — 3 listed sites

Translational Genomics Research Institute
Phoenix, Arizona, United States
Site recruitment: Not reported
University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported
Florida Institute for Human and Machine Cognition
Pensacola, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants

ClinicalTrials.gov · NCT02205034 · Registry updated: 2024-02-21

Condition / research focus: Prader Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2013-05. Completion: 2014-07 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: Oxytocin (Syntocinon)

Where the study takes place — 1 listed sites

Centre de réfrence Prader-Willi, Hospital of infants
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH

ClinicalTrials.gov · NCT02775773 · Registry updated: 2024-02-08

Condition / research focus: Post Partum Haemorrhage
Sponsor: Azienda U.S.L. 1 di Massa e Carrara
Countries with listed sites: Italy
Registry dates and results: Start: 2018-01-30. Completion: 2018-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid (drug) — also listed as: TXA
Oxytocin (drug) — also listed as: OXY

Where the study takes place — 1 listed sites

Department of Ostetricia e Ginecologia-Ospedale delle Apuane
Massa, MS, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3WithdrawnINTERVENTIONAL

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015)

ClinicalTrials.gov · NCT02503319 · Registry updated: 2024-02-08

Condition / research focus: Postpartum Hemorrhage
Sponsor: Azienda U.S.L. 1 di Massa e Carrara
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-01. Completion: 2016-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid (drug) — also listed as: TXA
Tranexamic Acid (drug) — also listed as: TXA
Oxytocin (drug) — also listed as: OXY

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

ClinicalTrials.gov · NCT02545127 · Registry updated: 2024-02-07

Condition / research focus: Preterm Delivery; Inadequate Milk Production
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2021-05-28. Completion: 2022-11-11 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merotocin (drug) — also listed as: FE 202767
Placebo (drug)

Where the study takes place — 10 listed sites

Ferring Investigational Site
New Haven, Connecticut, United States
Site recruitment: Not reported
Ferring Investigational Site
South Bend, Indiana, United States
Site recruitment: Not reported
Ferring Investigational Site
Baltimore, Maryland, United States
Site recruitment: Not reported
Ferring Investigational Site
Boston, Massachusetts, United States
Site recruitment: Not reported
Ferring Investigational Site
Valhalla, New York, United States
Site recruitment: Not reported
Ferring Investigational Site
Raleigh, North Carolina, United States
Site recruitment: Not reported
Ferring Investigational Site
Cincinnati, Ohio, United States
Site recruitment: Not reported
Ferring Investigational Site
Charleston, South Carolina, United States
Site recruitment: Not reported
Ferring Investigational Site
Houston, Texas, United States
Site recruitment: Not reported
Ferring Investigational Site
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

The Effects of Oxytocin in Obese Adults

ClinicalTrials.gov · NCT03043053 · Registry updated: 2024-02-07

Condition / research focus: Obesity
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2017-07-01. Completion: 2022-07-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin nasal spray (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

After Caesarean Section Oxitocin Breast Massage Anthropometric Characteristics of the Newborn

ClinicalTrials.gov · NCT06242886 · Registry updated: 2024-02-05

Condition / research focus: Breastfeeding, Exclusive; Breastfeeding
Sponsor: Halic University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2023-02-20. Completion: 2023-09-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin massage (behavioral)
and Breast massage (behavioral)

Where the study takes place — 1 listed sites

Fatma Şule Bilgiç
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Oxytocin Nasal Inhalation on Empathy Analgesia

ClinicalTrials.gov · NCT05823441 · Registry updated: 2024-02-01

Condition / research focus: Oxytocin; Pain; Empathy; Social Familiarity; Analgesia
Sponsor: Peking University People's Hospital
Countries with listed sites: China
Registry dates and results: Start: 2023-06-03. Completion: 2024-01-21 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Placebo (drug)
Stranger (behavioral)
Acquaintance (behavioral)

Where the study takes place — 1 listed sites

Peking University People's Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Treating Stress and Anxiety in Individuals With Alcohol Use Disorder (AUD)

ClinicalTrials.gov · NCT06224127 · Registry updated: 2024-01-25

Condition / research focus: Anxiety Disorders; Alcohol Use Disorder; Stress, Psychological
Sponsor: Soovu Labs Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2024-07-15. Completion: 2025-03-30 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

active heat (device)
Active c tactile fiber stimulation (drug)
sham heat (device)
Sham c tactile fiber stimulation (device)

Where the study takes place — 1 listed sites

Soovu Labs Inbc.
Seattle, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of Oxytocin on Reinforcement Learning and Interoception

ClinicalTrials.gov · NCT05245708 · Registry updated: 2024-01-19

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2021-04-15. Completion: 2021-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug)
intranasal placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China (UESTC)
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Cerebral Synchronization Between Mothers and Their Newborns During Breastfeeding

ClinicalTrials.gov · NCT05821569 · Registry updated: 2024-01-18

Condition / research focus: Depression, Postpartum
Sponsor: IRCCS Burlo Garofolo
Countries with listed sites: Italy
Registry dates and results: Start: 2024-01-09. Completion: 2024-09-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Standard approach (other)
Biological nurturing (other)

Where the study takes place — 1 listed sites

IRCCS Burlo Garofolo
Trieste, Italy
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Association Between Labor Induction and Birth Weight in Cases of Fetal Macrosomia: The MACROMODA Cohort Study

ClinicalTrials.gov · NCT06198881 · Registry updated: 2024-01-10

Condition / research focus: Birth Weight; Macrosomia, Fetal
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2023-10-01. Completion: 2024-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 3 listed sites

Hôpital Femme-Mère-Enfant
Bron, France
Site recruitment: Not reported
Croix Rousse Hospital
Lyon, France
Site recruitment: Not reported
Hôpital Lyon Sud
Pierre-Bénite, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Uterine Massage After Vaginal Delivery

ClinicalTrials.gov · NCT03858569 · Registry updated: 2024-01-09

Condition / research focus: Postpartum Hemorrhage
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2019-01-15. Completion: 2019-09-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

active management of third stage of labor (procedure)

Where the study takes place — 1 listed sites

Kanuni SSTRH
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes

ClinicalTrials.gov · NCT06181396 · Registry updated: 2023-12-26

Condition / research focus: Delivery Complication; Cesarean Delivery Affecting Fetus
Sponsor: Rambam Health Care Campus
Countries with listed sites: Israel
Registry dates and results: Start: 2023-10-01. Completion: 2026-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Rambam medical health campus
Haifa, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Cervical Traction and Postpartum Hemorrhage

ClinicalTrials.gov · NCT06179147 · Registry updated: 2023-12-21

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ege University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2022-11-01. Completion: 2023-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cervical traction (other)

Where the study takes place — 1 listed sites

Ege University Faculty of Health Sciences
Karşiyaka, İ̇zmi̇r, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Reactivity of Patients With Borderline Personality Disorder to an Ecological Interpersonal Stress

ClinicalTrials.gov · NCT03602521 · Registry updated: 2023-12-20

Condition / research focus: Female; Borderline Personality Disorder
Sponsor: University Hospital, Montpellier
Countries with listed sites: France
Registry dates and results: Start: 2019-02-27. Completion: 2023-08-18 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Interpersonal stress (other)

Where the study takes place — 1 listed sites

Hospital Lapeyronie
Montpellier, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Intranasal Oxytocin for Frontotemporal Dementia

ClinicalTrials.gov · NCT03260920 · Registry updated: 2023-12-15

Condition / research focus: Frontotemporal Dementia
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Countries with listed sites: Canada · United States
Registry dates and results: Start: 2018-01-31. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug) — also listed as: Intranasal Oxytocin

Where the study takes place — 11 listed sites

UCLA
Los Angeles, California, United States
Site recruitment: Not reported
University of California, San Francisco
San Francisco, California, United States
Site recruitment: Not reported
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States
Site recruitment: Not reported
Columbia University Medical Center
New York, New York, United States
Site recruitment: Not reported
University of Washington
Seattle, Washington, United States
Site recruitment: Not reported
University of British Columbia
Vancouver, British Columbia, Canada
Site recruitment: Not reported
Parkwood Institute
London, Ontario, Canada
Site recruitment: Not reported
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Site recruitment: Not reported
University Health Network
Toronto, Ontario, Canada
Site recruitment: Not reported
Montreal Neurological Institute and Hospital
Montreal, Quebec, Canada
Site recruitment: Not reported
Laval University
Québec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Carbetocin in the Prevention of Primary Postpartum Haemorrhage

ClinicalTrials.gov · NCT06159959 · Registry updated: 2023-12-07

Condition / research focus: Post Partum Hemorrhage
Sponsor: Ministry of Health and Population, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2023-01-01. Completion: 2023-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Oxytocin

Where the study takes place — 1 listed sites

Kasr- Alainy Hospitals
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity

ClinicalTrials.gov · NCT05289869 · Registry updated: 2023-11-29

Condition / research focus: Pregnant Patients With Obesity
Sponsor: Ohio State University
Countries with listed sites: United States
Registry dates and results: Start: 2022-04-06. Completion: 2022-10-28 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

High-dose oxytocin (drug)
Low-dose oxytocin (drug)

Where the study takes place — 1 listed sites

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →